Lantheus Holdings (LNTH) Net Equity Issued and Repurchased (2014 - 2025)

Lantheus Holdings' (LNTH) quarterly Net Equity Issued and Repurchased came in at $2.0 million in Q1 2025, up 8.78% year-on-year from $1.8 million in Q1 2024, and up 21.88% on a QoQ basis from $1.6 million in Q3 2024.

Lantheus Holdings (LNTH) Net Equity Issued and Repurchased (2014 - 2025) Analysis & Trends

Lantheus Holdings (LNTH) has 11 years of Net Equity Issued and Repurchased data on file, last reported at $2.0 million in Q1 2025.

  • On a quarterly basis, Net Equity Issued and Repurchased rose 8.78% year-over-year to $2.0 million in Q1 2025; TTM through Mar 2026 was $3.6 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $3.4 million, up 78.48% from the prior year.
  • Net Equity Issued and Repurchased for Q1 2025 stood at $2.0 million, up from $1.6 million in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for LNTH reached as high as $2.0 million in Q1 2025 and fell as low as -$1000.0 in Q4 2021.
  • Historically, Net Equity Issued and Repurchased has averaged $950800.0 across 5 years, with a median of $869000.0 in 2022.
  • Across the five-year window, Net Equity Issued and Repurchased dropped 7.92% in 2021 and jumped 93.94% in 2024, its largest moves.
  • Year by year, Net Equity Issued and Repurchased stood at -$1000.0 in 2021, then soared by 79900.0% to $798000.0 in 2022, then rose by 24.44% to $993000.0 in 2023, then jumped by 63.85% to $1.6 million in 2024, then rose by 21.88% to $2.0 million in 2025.
  • Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $2.0 million in Q1 2025, $1.6 million in Q3 2024, and $1.8 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 500,000.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.98 Mn
Mar 31, 2025 1.98 Mn
Sep 30, 2024 1.63 Mn
Sep 30, 2024 1.63 Mn
Mar 31, 2024 1.82 Mn
Mar 31, 2024 1.82 Mn
Sep 30, 2023 993,000.00
Sep 30, 2023 993,000.00
Mar 31, 2023 940,000.00
Mar 31, 2023 940,000.00
Sep 30, 2022 798,000.00
Sep 30, 2022 798,000.00
Mar 31, 2022 577,000.00
Mar 31, 2022 577,000.00
Dec 31, 2021 -1,000.00
Dec 31, 2021 -1,000.00
Sep 30, 2021 431,000.00
Sep 30, 2021 431,000.00
Mar 31, 2021 337,000.00
Mar 31, 2021 337,000.00